ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 130 filers reported holding ACCELERON PHARMA INC in Q1 2016. The put-call ratio across all filers is 3.66 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $7,994,000 | +68.1% | 46,449 | +22.6% | 0.00% | +50.0% |
Q2 2021 | $4,756,000 | +0.7% | 37,900 | +8.8% | 0.00% | 0.0% |
Q1 2021 | $4,723,000 | +7.9% | 34,831 | +1.8% | 0.00% | 0.0% |
Q4 2020 | $4,376,000 | -3.7% | 34,201 | -15.3% | 0.00% | 0.0% |
Q3 2020 | $4,543,000 | +24.6% | 40,371 | +5.5% | 0.00% | 0.0% |
Q2 2020 | $3,646,000 | +45.3% | 38,267 | +37.0% | 0.00% | +100.0% |
Q1 2020 | $2,510,000 | +80.4% | 27,938 | +6.4% | 0.00% | 0.0% |
Q4 2019 | $1,391,000 | +58.1% | 26,251 | +17.8% | 0.00% | – |
Q3 2019 | $880,000 | +15.8% | 22,279 | +20.4% | 0.00% | – |
Q2 2019 | $760,000 | -8.0% | 18,502 | +4.3% | 0.00% | – |
Q1 2019 | $826,000 | +14.2% | 17,744 | +6.8% | 0.00% | -100.0% |
Q4 2018 | $723,000 | -6.6% | 16,608 | +22.8% | 0.00% | 0.0% |
Q3 2018 | $774,000 | +17.6% | 13,521 | -0.3% | 0.00% | 0.0% |
Q2 2018 | $658,000 | +16.5% | 13,565 | -6.2% | 0.00% | – |
Q1 2018 | $565,000 | -21.6% | 14,454 | -14.8% | 0.00% | -100.0% |
Q4 2017 | $721,000 | +22.6% | 16,956 | +6.9% | 0.00% | – |
Q3 2017 | $588,000 | +84.9% | 15,862 | +51.5% | 0.00% | – |
Q2 2017 | $318,000 | +26.2% | 10,470 | +9.7% | 0.00% | – |
Q1 2017 | $252,000 | +2.0% | 9,547 | -1.1% | 0.00% | – |
Q4 2016 | $247,000 | +71.5% | 9,653 | +144.1% | 0.00% | – |
Q3 2016 | $144,000 | -0.7% | 3,954 | -6.2% | 0.00% | – |
Q2 2016 | $145,000 | +33.0% | 4,214 | +4.3% | 0.00% | – |
Q1 2016 | $109,000 | -25.9% | 4,041 | +33.8% | 0.00% | – |
Q4 2015 | $147,000 | +101.4% | 3,021 | 0.0% | 0.00% | – |
Q3 2015 | $73,000 | -21.5% | 3,021 | 0.0% | 0.00% | – |
Q2 2015 | $93,000 | -21.2% | 3,021 | 0.0% | 0.00% | – |
Q1 2015 | $118,000 | +0.9% | 3,021 | 0.0% | 0.00% | – |
Q4 2014 | $117,000 | +20.6% | 3,021 | -7.6% | 0.00% | – |
Q3 2014 | $97,000 | – | 3,269 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |